Login/Sign Up

MRP ₹3582
(Inclusive of all Taxes)
₹358.2 Cashback (10%)
EMGRAST M 500MCG INJECTION is used to treat neutropenia, a deficiency of specific white blood cells caused by cancer, bone marrow transplant, chemotherapy, or other diseases. It contains Sargramostim, a growth factor that stimulates the formation of white blood cells and helps reduce the chances of infection in cancer patients receiving chemotherapy.
Provide Delivery Location
About EMGRAST M 500MCG INJECTION
EMGRAST M 500MCG INJECTION belongs to the class of medications called colony-stimulating factors used to treat neutropenia, a deficiency of specific white blood cells caused by cancer, bone marrow transplant, chemotherapy, or other diseases. EMGRAST M 500MCG INJECTION helps reduce the chance of infection in cancer patients and those receiving chemotherapy medicines. Neutropenia is a condition in which the quantity of neutrophils (white blood cells) in the blood is reduced.
EMGRAST M 500MCG INJECTION contains Sargramostim, a growth factor that stimulates the formation of white blood cells and helps reduce the chances of infection in cancer patients receiving chemotherapy.
A healthcare professional will administer EMGRAST M 500MCG INJECTION. Sometimes, you may experience injection site responses such as pain, redness, or swelling. You may also experience nausea, vomiting, headache, diarrhoea, stomach pain, mouth sores, loss of appetite, hair loss and bone, joint, or muscle pain. Most of these side effects do not necessitate medical treatment and will gradually fade over time. However, if you suffer these side effects regularly, you should consult your doctor.
It is not suggested to use EMGRAST M 500MCG INJECTION in those who have had severe allergic responses, including anaphylaxis, to human granulocyte-macrophage colony-stimulating factor, yeast-derived products, or any component of EMGRAST M 500MCG INJECTION. To rule out any negative effects, keep your doctor informed about your medical condition and all medications you take. Inform your doctor if you are pregnant, intend to become pregnant, or are currently breastfeeding. Contact your doctor if you become pregnant while using EMGRAST M 500MCG INJECTION.
Uses of EMGRAST M 500MCG INJECTION
EMGRAST M 500MCG INJECTION is used in the treatment of Neutropenia. The detailed uses of EMGRAST M 500MCG INJECTION are as follows:

Have a query?
Directions for Use
Medicinal Benefits
EMGRAST M 500MCG INJECTION contains 'Sargramostim,' which is a growth factor. It belongs to the cytokine family of proteins and is extremely similar to a natural protein (granulocyte-colony stimulating factor) produced by the body. EMGRAST M 500MCG INJECTION acts by encouraging the bone marrow to generate more white blood cells, aiding infection resistance. EMGRAST M 500MCG INJECTION is used to boost white blood cell count following cancer treatment or chemotherapy, bone marrow transplantation, severe persistent neutropenia, neutropenia in HIV patients, and before stem cell donation.
How EMGRAST M 500MCG INJECTION Works
Storage
What if I have taken an overdose of EMGRAST M 500MCG INJECTION
Drug Warnings
Extreme caution and special care should be taken while using EMGRAST M 500MCG INJECTION in patients with heart disorders, liver or renal dysfunction, leukocytosis (elevated white blood cell count), myeloproliferative disorder (blood cancers), pulmonary impairment, asphyxia (a condition of deficient supply of oxygen) and prematurity or underweight in infancy and respiratory symptoms. So, keep your doctor informed about your medical condition and all the medicines you are taking to rule out any side effects.
Drug-Drug Interactions
Login/Sign Up
Drug-Food Interactions
Login/Sign Up
Diet & Lifestyle Advise
Habit Forming
Therapeutic Class
Alcohol
Caution
It is unknown whether consuming alcohol with EMGRAST M 500MCG INJECTION is safe. However, as a precaution, it is best to avoid or limit alcohol consumption.
Pregnancy
Caution
It is not known if EMGRAST M 500MCG INJECTION will harm your unborn baby. So, inform your doctor if you are pregnant or planning to become pregnant; your doctor will prescribe only if the benefits outweigh the risks.
Breast Feeding
Caution
Your doctor may advise you to discontinue the medicine or breastfeeding based on your medical condition.
Driving
Caution
The ability to drive or utilize machines is unaffected by EMGRAST M 500MCG INJECTION. However, do not drive or operate machinery if you feel sleepy or dizzy after taking your medicine.
Liver
Caution
Caution should be exercised while using EMGRAST M 500MCG INJECTION in patients with hepatic dysfunction. Monitoring of patients with hepatic dysfunction is recommended.
Kidney
Caution
Caution should be exercised while using EMGRAST M 500MCG INJECTION in patients with renal dysfunction. Monitoring of patients with renal dysfunction is recommended.
Children
Safe if prescribed
Your doctor will prescribe only if the benefits outweigh the risks.
Heart
EMGRAST M 500MCG INJECTION can be used in patients with heart problems, but it requires careful monitoring. It may affect heart rhythm or blood pressure, and can cause fluid retention or worsen preexisting cardiac conditions. Your doctor will assess the risks and benefits before prescribing it and may adjust your treatment plan accordingly.
Geriatrics
Caution
Geriatric patients can receive EMGRAST M 500MCG INJECTION, but with extra caution and monitoring. Older adults may be more sensitive to side effects like fluid retention, changes in blood pressure, or heart rhythm issues, so doctors typically adjust the dosage and watch closely for any complications.
EMGRAST M 500MCG INJECTION is used to treat Neutropenia.
EMGRAST M 500MCG INJECTION contains 'Sargramostim,' which is a growth factor that stimulates the formation of white blood cells and helps to reduce the chances of infection in cancer patients receiving chemotherapy.
This medication should not be used in individuals who have a known allergy to Sargramostim, filgrastim, or any of the inactive components present in it.
EMGRAST M 500MCG INJECTION may interfere with certain lab tests, such as bone imaging and blood testing, potentially resulting in incorrect test findings. Make sure your doctor and laboratory personnel are aware that you take EMGRAST M 500MCG INJECTION.
EMGRAST M 500MCG INJECTION may sometimes cause capillary leak syndrome, which causes blood leakage from small blood vessels. Inform your doctor immediately if you notice difficulty breathing, swelling, a feeling of fullness, and tiredness.
Country of origin
Manufacturer/Marketer address
Keep Refrigerated. Do not freeze.Prepaid payment required.
We provide you with authentic, trustworthy and relevant information
Buy best Neoplastic Disorders products by
Intas Pharmaceuticals Ltd
Dr Reddy's Laboratories Ltd
Celon Laboratories Pvt Ltd
Natco Pharma Ltd
Cipla Ltd
Adley Formulations
BDR Pharmaceuticals Internationals Pvt Ltd
Sun Pharmaceutical Industries Ltd
Admac Lifesciences(Oncology)
Halsted Pharma Pvt Ltd
Glenmark Pharmaceuticals Ltd
Neon Laboratories Ltd
United Biotech Pvt Ltd
Alkem Laboratories Ltd
Samarth Life Sciences Pvt Ltd
Zydus Cadila
Zydus Healthcare Ltd
Emcure Pharmaceuticals Ltd
Axiommax Oncology Pvt Ltd
GLS Pharma Ltd
Mylan Pharmaceuticals Pvt Ltd
Hetero Drugs Ltd
Hetero Healthcare Pvt Ltd
Fresenius Kabi India Pvt Ltd
Pfizer Ltd
Torrent Pharmaceuticals Ltd
Cadila Healthcare Ltd
Getwell Life Sciences India Pvt Ltd
Therdose Pharma Pvt Ltd
Khandelwal Laboratories Pvt Ltd
Novartis India Ltd
Lupin Ltd
Adley Pharmaceuticals Ltd
Aureate Healthcare
Biochem Pharmaceutical Industries Ltd
RPG Life Sciences Ltd
Abbott India Ltd
Delarc Pharmaceuticals Pvt Ltd
Zee Laboratories Ltd
Amps Biotech Biotech Pvt Ltd
Shilpa Medicare Ltd
Wembrace Biopharma Pvt Ltd
Aimcad Biotech Pvt Ltd
Getwell Oncology Pvt Ltd
Msn Laboratories Pvt Ltd
Reliance Formulation Pvt Ltd
Allieva Pharma Pvt Ltd
Astra Zeneca Pharma India Ltd
Lucien Life Sciences
Getwell Pharmaceutical Pvt Ltd
MEDICAMEN BIOTECH LTD
Medion Biotech Pvt Ltd
Bhardwaj India Pvt Ltd
Caitlin Oncology
Del Trade International Pvt Ltd
Medaegis Biotek Pvt Ltd
Panacea Biotec Ltd
Cadila Pharmaceuticals Ltd
Dabur India Ltd
Oncostar Pharma Pvt Ltd
Sarabhai Chemicals (India) Pvt Ltd
Bangalore Pharmaceutical and Research Laboratory Pvt Ltd (BPRL)
Cytogen
Symbion Lifescience
Vhb Life Sciences Inc
Zuvius Lifesciences Pvt Ltd
Amneal Healthcare Pvt Ltd
Ipca Laboratories Ltd
Miracalus Pharma Pvt Ltd
Bruck Pharma Pvt Ltd
Eli Lilly and Company (India) Pvt Ltd
Hilfen Pharmaceuticals Pvt Ltd
Medicamen Biotech Ltd
Adley Oncology
Admac Pharma Ltd
Eris Life Sciences Ltd
Johnson & Johnson Pvt Ltd
Maximal Healthcare Pvt Ltd
Reliance Life Sciences Pvt Ltd
Sayre Therapeutics Pvt Ltd
Akumentis Healthcare Ltd
Biocon Ltd
Caitlin Biotech Pvt Ltd
Ferring Pharmaceuticals Pvt Ltd
Fresenius Kabi Oncology Ltd
Zuventus Healthcare Ltd
Astellas Pharma India Pvt Ltd
Boehringer Ingelheim India Pvt Ltd
Mankind Pharma Pvt Ltd
Roche Diagnostics India Pvt Ltd
Selway Lifesciences Pvt Ltd
Trikem Remedies Llp
Adley & Bdl
Aprazer Healthcare Pvt Ltd
Aureate Pharma
Caitlin Life Care
Corona Remedies Pvt Ltd
Eisai Pharmaceuticals India Pvt Ltd
GlaxoSmithKline Pharmaceuticals Ltd
Gynofem Healthcare Pvt Ltd